A detailed history of Concurrent Investment Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 36,431 shares of NVO stock, worth $3.83 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
36,431
Previous 35,624 2.27%
Holding current value
$3.83 Million
Previous $5.08 Billion 14.69%
% of portfolio
0.13%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$119.07 - $145.42 $96,089 - $117,353
807 Added 2.27%
36,431 $4.34 Billion
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $67,122 - $80,359
547 Added 1.56%
35,624 $5.08 Billion
Q1 2024

May 07, 2024

BUY
$102.11 - $135.92 $1.89 Million - $2.51 Million
18,466 Added 111.17%
35,077 $4.5 Billion
Q4 2023

Apr 15, 2024

BUY
$87.78 - $105.45 $1.46 Million - $1.75 Million
16,611 New
16,611 $1.72 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Concurrent Investment Advisors, LLC Portfolio

Follow Concurrent Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concurrent Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concurrent Investment Advisors, LLC with notifications on news.